Literature DB >> 35732083

Automated versus manual analysis of body composition measures on computed tomography in patients with bladder cancer.

Francesca Rigiroli1, Dylan Zhang2, Jeroen Molinger3, Yingqi Wang4, Andrew Chang5, Paul E Wischmeyer6, Brant A Inman7, Rajan T Gupta8.   

Abstract

PURPOSE: Manual measurement of body composition on computed tomography (CT) is time-consuming, limiting its clinical use. We validate a software program, Automatic Body composition Analyzer using Computed tomography image Segmentation (ABACS), for the automated measurement of body composition by comparing its performance to manual segmentation in a cohort of patients with bladder cancer.
METHOD: We performed a retrospective analysis of 285 patients treated for bladder cancer at the Duke University Health System from 1996 to 2017. Abdominal CT images were manually segmented at L3 using Slice-O-Matic. Automated segmentation was performed with ABACS on the same L3-level images. Measures of interest were skeletal muscle (SM) area, subcutaneous adipose tissue (SAT) area, and visceral adipose tissue (VAT) area. SM index, SAT index, and VAT index were calculated by dividing component areas by patient height2 (m2). Patients were dichotomized as sarcopenic, having excessive subcutaneous fat, or having excessive visceral fat using published cut-off values. Agreement between manual and automated segmentation was assessed using the Pearson product-moment correlation coefficient (PPMCC), the interclass correlation coefficient (ICC3), and the kappa statistic (κ).
RESULTS: There was strong agreement between manual and automatic segmentation, with PPMCCs > 0.90 and ICC3s > 0.90 for SM, SAT, and VAT areas. Categorization of patients as sarcopenic (κ = 0.73), having excessive subcutaneous fat (κ = 0.88), or having excessive visceral fat (κ = 0.90) displayed high agreement between methods.
CONCLUSIONS: Automated segmentation of body composition measures on CT using ABACS performs similarly to manual analysis and may expedite data collection in body composition research.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adiposity; Automation; Bladder cancer; Body composition; Sarcopenia

Mesh:

Year:  2022        PMID: 35732083      PMCID: PMC9398959          DOI: 10.1016/j.ejrad.2022.110413

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   4.531


  18 in total

1.  Evaluation of body Computed Tomography-determined sarcopenia in breast cancer patients and clinical outcomes: A systematic review.

Authors:  Federica Rossi; Francesca Valdora; Bianca Bignotti; Lorenzo Torri; Giulia Succio; Alberto Stefano Tagliafico
Journal:  Cancer Treat Res Commun       Date:  2019-06-11

Review 2.  Human body composition: advances in models and methods.

Authors:  S B Heymsfield; Z Wang; R N Baumgartner; R Ross
Journal:  Annu Rev Nutr       Date:  1997       Impact factor: 11.848

Review 3.  Body composition assessment and sarcopenia in patients with pancreatic cancer: a systematic review and meta-analysis.

Authors:  James Bundred; Sivesh K Kamarajah; Keith J Roberts
Journal:  HPB (Oxford)       Date:  2019-06-29       Impact factor: 3.647

Review 4.  Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact.

Authors:  C M Prado; S J Cushen; C E Orsso; A M Ryan
Journal:  Proc Nutr Soc       Date:  2016-01-08       Impact factor: 6.297

5.  Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.

Authors:  Carla M M Prado; Jessica R Lieffers; Linda J McCargar; Tony Reiman; Michael B Sawyer; Lisa Martin; Vickie E Baracos
Journal:  Lancet Oncol       Date:  2008-06-06       Impact factor: 41.316

6.  Body Composition Assessment in Axial CT Images Using FEM-Based Automatic Segmentation of Skeletal Muscle.

Authors:  Karteek Popuri; Dana Cobzas; Nina Esfandiari; Vickie Baracos; Martin Jägersand
Journal:  IEEE Trans Med Imaging       Date:  2015-09-22       Impact factor: 10.048

7.  Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis.

Authors:  Emanuele Rinninella; Marco Cintoni; Pauline Raoul; Carmelo Pozzo; Antonia Strippoli; Emilio Bria; Giampaolo Tortora; Antonio Gasbarrini; Maria Cristina Mele
Journal:  Clin Nutr       Date:  2019-11-01       Impact factor: 7.324

8.  Diet and Exercise Are not Associated with Skeletal Muscle Mass and Sarcopenia in Patients with Bladder Cancer.

Authors:  Yingqi Wang; Andrew Chang; Wei Phin Tan; Joseph J Fantony; Ajay Gopalakrishna; Gregory J Barton; Paul E Wischmeyer; Rajan T Gupta; Brant A Inman
Journal:  Eur Urol Oncol       Date:  2019-05-25

9.  Subcutaneous adiposity is an independent predictor of mortality in cancer patients.

Authors:  Maryam Ebadi; Lisa Martin; Sunita Ghosh; Catherine J Field; Richard Lehner; Vickie E Baracos; Vera C Mazurak
Journal:  Br J Cancer       Date:  2017-06-06       Impact factor: 7.640

10.  Evaluation of automated computed tomography segmentation to assess body composition and mortality associations in cancer patients.

Authors:  Elizabeth M Cespedes Feliciano; Karteek Popuri; Dana Cobzas; Vickie E Baracos; Mirza Faisal Beg; Arafat Dad Khan; Cydney Ma; Vincent Chow; Carla M Prado; Jingjie Xiao; Vincent Liu; Wendy Y Chen; Jeffrey Meyerhardt; Kathleen B Albers; Bette J Caan
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-04-20       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.